HeartBeam, Inc. (BEATW): Operating Income

Annual figures by period end, from SEC filings.

-$21.14M

Year ended 2025-12-31

-$20.41M

Trailing 12 months to 2026-06-30

2020-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$21.14M	n/m	2026-03-12, From 2025-01-01
2024-12-31	-$19.89M	n/m	2026-03-12, From 2024-01-01
2023-12-31	-$15.31M	n/m	2025-03-13, From 2023-01-01
2022-12-31	-$13.03M	n/m	2024-03-20, From 2022-01-01
2021-12-31	-$2.29M	n/m	2023-03-16, From 2021-01-01
2020-12-31	-$788.0K	n/a	2022-03-24, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
HeartBeam, Inc. (BEATW)	2025-12-31	-$21.14M	n/m
Aethlon Medical Inc (AEMD)	2026-03-31	-$7.29M	n/m
QTREX Quantum Ltd. (QTEX)	2025-12-31	-$13.62M	n/m
Biotricity Inc. (BTCY)	2026-03-31	$1.69M	n/m
Medinotec Inc. (MDNC)	2026-02-28	$1.09M	-65.7%
Bluejay Diagnostics, Inc. (BJDX)	2025-12-31	-$6.95M	n/m
Autonomix Medical, Inc. (AMIX)	2026-03-31	-$17.03M	n/m
Glucotrack, Inc. (GCTK)	2025-12-31	-$16.09M	n/m
RenovoRx, Inc. (RNXT)	2025-12-31	-$12.51M	n/m

Compare BEATW, AEMD, QTEX, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗